Klp Kapitalforvaltning As Ligand Pharmaceuticals Inc Call Options Transaction History
Klp Kapitalforvaltning As
- $20.6 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LGND
# of Institutions
274Shares Held
18.3MCall Options Held
32.2KPut Options Held
7K-
Black Rock Inc. New York, NY2.87MShares$327 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$238 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$115 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3884KShares$101 Million0.11% of portfolio
-
State Street Corp Boston, MA744KShares$84.7 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.92B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...